IL6R and coronary artery disorder: IL-6 has been reported to exert both inflammatory and anti-inflammatory actions [49] and a single nucleotide polymorphism (SNP), Asp358Ala, has been identified in the IL-6R to reduce inflammation and the risk of developing coronary heart disease (CHD) [50,51], although the mechanisms for this remain unclear [52].